Edgardo Chouela

1.0k total citations
38 papers, 599 citations indexed

About

Edgardo Chouela is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Edgardo Chouela has authored 38 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Dermatology, 11 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Edgardo Chouela's work include Psoriasis: Treatment and Pathogenesis (8 papers), Cancer and Skin Lesions (7 papers) and Nail Diseases and Treatments (6 papers). Edgardo Chouela is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Cancer and Skin Lesions (7 papers) and Nail Diseases and Treatments (6 papers). Edgardo Chouela collaborates with scholars based in Argentina, Brazil and Switzerland. Edgardo Chouela's co-authors include Graciela Pellerano, Ronald Pedersen, Armando Garsd, Ulrich Mrowietz, Lotus Mallbris, Robert Boggs, Valentina Marino, L. Puig, Bruce Freundlich and C. Molta and has published in prestigious journals such as Hepatology, British Journal of Dermatology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Edgardo Chouela

30 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edgardo Chouela Argentina	13	196	191	185	133	112	38	599
David Rubem Azulay Brazil	16	162 0.8×	64 0.3×	122 0.7×	189 1.4×	53 0.5×	51	560
I. H. Coulson United Kingdom	15	382 1.9×	82 0.4×	42 0.2×	119 0.9×	90 0.8×	57	715
M. J. Boffa United Kingdom	13	145 0.7×	183 1.0×	158 0.9×	97 0.7×	83 0.7×	21	538
Soumiya Chiheb Morocco	10	145 0.7×	96 0.5×	61 0.3×	213 1.6×	52 0.5×	89	481
Vijay Zawar India	16	483 2.5×	70 0.4×	188 1.0×	380 2.9×	135 1.2×	119	917
V. M. Yates United Kingdom	11	214 1.1×	97 0.5×	62 0.3×	171 1.3×	91 0.8×	23	533
Jackson Machado‐Pinto Brazil	11	111 0.6×	99 0.5×	37 0.2×	136 1.0×	41 0.4×	27	453
P. Höger Germany	14	246 1.3×	114 0.6×	93 0.5×	148 1.1×	23 0.2×	65	586
Athanassios Kolivras Belgium	14	283 1.4×	51 0.3×	222 1.2×	165 1.2×	67 0.6×	46	670
Robert B. Skinner United States	13	233 1.2×	172 0.9×	53 0.3×	273 2.1×	51 0.5×	39	637

Countries citing papers authored by Edgardo Chouela

Since Specialization

Citations

This map shows the geographic impact of Edgardo Chouela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgardo Chouela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgardo Chouela more than expected).

Fields of papers citing papers by Edgardo Chouela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgardo Chouela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgardo Chouela. The network helps show where Edgardo Chouela may publish in the future.

Co-authorship network of co-authors of Edgardo Chouela

This figure shows the co-authorship network connecting the top 25 collaborators of Edgardo Chouela. A scholar is included among the top collaborators of Edgardo Chouela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgardo Chouela. Edgardo Chouela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strober, Bruce, Alice B. Gottlieb, P.C.M. KERKHOF, et al.. (2018). Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials. British Journal of Dermatology. 180(1). 67–75. 24 indexed citations

Mrowietz, Ulrich, Edgardo Chouela, Lotus Mallbris, et al.. (2014). Pruritus and quality of life in moderate‐to‐severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. Journal of the European Academy of Dermatology and Venereology. 29(6). 1114–1120. 65 indexed citations

Strohal, Robert, L. Puig, Edgardo Chouela, et al.. (2012). The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial). Journal of Dermatological Treatment. 24(3). 169–178. 58 indexed citations

Khraishi, Majed, et al.. (2012). High Prevalence of Psoriatic Arthritis in a Cohort of Patients with Psoriasis Seen in a Dermatology Practice. Journal of Cutaneous Medicine and Surgery. 16(2). 122–127. 34 indexed citations

Chouela, Edgardo. (2011). Epidemiología y genética de la psoriasis. 17(3). 236–239. 1 indexed citations

Chouela, Edgardo, et al.. (2010). Community study of fixed-combination adapalene 0.1% and benzoyl peroxide 2.5% in acne.. PubMed. 8(1). 17–22. 8 indexed citations

Stengel, Fernando, et al.. (2009). Control of Moderate‐to‐Severe Plaque Psoriasis with Efalizumab: 24‐Week, Open‐Label, Phase IIIb/IV Latin American Study Results. PubMed. 2(4). 71–78. 7 indexed citations

Chouela, Edgardo, et al.. (2009). Siliconoma. Comunicación de un caso. 15(4). 278–281.

Takahashí, Maria Denise Fonseca, Edgardo Chouela, Ana Maria Ferreira Roselino, et al.. (2009). Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24‐Week Latin American Study. PubMed. 3(1). 1–8. 6 indexed citations

10.

Stengel, Fernando, et al.. (2007). Brooke–Spiegler syndrome – report of four families: treatment with CO₂ laser. International Journal of Dermatology. 46(6). 583–586. 24 indexed citations

11.

Chouela, Edgardo, et al.. (2004). Amelanotic Lentigo Maligna Melanoma. SKINmed Dermatology for the Clinician. 3(1). 41–44. 3 indexed citations

12.

Chouela, Edgardo, et al.. (2003). Zoon's balanitis: presentation of 15 patients, five treated with a carbon dioxide laser. International Journal of Dermatology. 42(4). 305–307. 28 indexed citations

13.

Lipozenčić, Jasna, M. Skerlev, Rosane Orofino‐Costa, et al.. (2002). A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. British Journal of Dermatology. 146(5). 816–823. 47 indexed citations

14.

Sookoian, Silvia, et al.. (2001). Development of Cutaneous Sarcoidosis in a Patient with Chronic Hepatitis C Treated with Interferon Alpha 2b. Journal of Cutaneous Medicine and Surgery. 5(5). 406–408. 17 indexed citations

15.

Chouela, Edgardo, et al.. (1999). Sunbed use in Buenos Aires, Argentina. Photodermatology Photoimmunology & Photomedicine. 15(3-4). 100–103. 4 indexed citations

16.

Chouela, Edgardo, et al.. (1999). Equivalent Therapeutic Efficacy and Safety of Ivermectin and Lindane in the Treatment of Human Scabies. Archives of Dermatology. 135(6). 651–5. 82 indexed citations

17.

Chouela, Edgardo, et al.. (1998). Derecho médico: historia clínica manuscrita e historia clínica informatizada: medios de prueba válidos en Sede Judicial.

18.

Pellerano, Graciela, et al.. (1997). ASPECTOS ECONOMICOS, SOCIALES Y LABORALES DE LA PSORIASIS II. 47(6). 263–268. 2 indexed citations

19.

Chouela, Edgardo, et al.. (1997). Head louse infestations: epidemiologic survey and treatment evaluation in Argentinian schoolchildren. International Journal of Dermatology. 36(11). 819–825. 42 indexed citations

20.

Chouela, Edgardo, et al.. (1996). HEPATITIS C VIRUS ANTIBODY (ANTI‐HCV): PREVALENCE IN PSORIASIS. International Journal of Dermatology. 35(11). 797–799. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact